Skip to main content
Faes Farma S.A. logo

Faes Farma S.A. — Investor Relations & Filings

Ticker · FAE ISIN · ES0134950F36 LEI · 959800FXZQY7U3P1G969 MC Manufacturing
Open in API
Filings indexed 193 across all filing types
Latest filing 2022-05-06 AGM Information
Country ES Spain
Listing MC FAE

About Faes Farma S.A.

https://faesfarma.com/en/

Faes Farma S.A. is a pharmaceutical company engaged in the research, development, manufacturing, and marketing of pharmaceutical products, healthcare solutions, and animal nutrition products. The company's pharmaceutical division develops treatments for conditions in therapeutic areas including allergy, gastroenterology, and immunology, with key proprietary molecules such as Bilastine, a leading antihistamine, and Calcifediol for Vitamin D deficiency. The animal nutrition business provides nutritional solutions and supplements for sustainable animal production. A core focus of the company is its investment in R&D to develop novel molecules and health solutions for its global markets.

Recent filings

Filing Released Lang Actions
Convocatoria Junta General de Accionistas 2022
AGM Information Classification · 99% confidence The document is explicitly titled "CONVOCATORIA DE LA JUNTA GENERAL DE ACCIONISTAS" (Call for the General Shareholders' Meeting) and details the date, location, and the Order of the Day (ORDEN DEL DIA) for the meeting. Key agenda items include the approval of annual accounts, re-election of directors, and capital increase proposals related to shareholder remuneration plans. This content directly relates to the formal process and materials distributed for an Annual General Meeting (AGM). Although it contains information that might overlap with other filings (like remuneration reports or capital changes), the primary purpose and structure of the document is the official convocation notice for the AGM. Therefore, the most appropriate classification is AGM-R (AGM Information).
2022-05-06 Spanish
Informe de negocio primer trimestre 2022
Interim / Quarterly Report Classification · 100% confidence The document is a detailed 'Informe de negocio Q1 2022' (Business Report Q1 2022) for Faes Farma. It contains comprehensive financial statements (income statement, revenue breakdown by region and product line), management analysis of business trends, and future outlooks. It is clearly a quarterly financial report rather than a simple earnings release or a presentation announcement, as it provides substantive financial data and detailed performance analysis for the first quarter of 2022. Q1 2022
2022-04-29 Spanish
Separación de cargos
Board/Management Information Classification · 98% confidence The document is a short communication (671 characters) from FAES FARMA, S.A. addressed to the CNMV (Comisión Nacional del Mercado de Valores), labeled as 'OTRA INFORMACIÓN RELEVANTE' (Other Relevant Information). The content announces a decision by the Board of Directors to separate the roles of Chairman and Chief Executive Officer, effective by the 2024 Shareholders' Meeting. This announcement concerns a change in the structure of the company's leadership and governance roles. This aligns best with the 'Board/Management Information' category (MANG), which covers announcements of changes in the company's board of directors or senior management.
2022-04-28 Spanish
Motivo de la notificación: Persona con Responsabilidad de Dirección
Director's Dealing Classification · 100% confidence The document is titled "MODELO DE NOTIFICACIÓN DE LAS OPERACIONES DE LAS PERSONAS CON RESPONSABILIDADES DE DIRECCIÓN Y DE LAS PERSONAS ESTRECHAMENTE VINCULADAS CON ELLAS" (Standard Form for Notification and Public Disclosure of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with Them). This form explicitly details transactions (Compra/Buy) made by a director ('SECRETARIO DEL CONSEJO' - Secretary of the Board) in the company's shares (Acción). This directly corresponds to the definition of Director's Dealing (insider trades). The available codes are reviewed: - 10-K, AR, IR, ER, MDA are financial reports. - CT is a transcript. - DIV, CAP, SHA, POS relate to dividends, financing, or share issuance/repurchase, but this is specifically about insider trading disclosure. - DEF 14A is remuneration. - The category that precisely matches the disclosure of personal share transactions by directors and executives is 'Director's Dealing' (Code: DIRS).
2022-03-23 Spanish
Presentación a analistas
Investor Presentation Classification · 98% confidence The document is titled 'Presentación analistas 22 de marzo de 2022' and contains extensive slides detailing 2021 financial results, growth strategy, product pipelines (Bilastina, Calcifediol, Mesalazina), market positions, and future outlook. The structure, use of figures, charts, and forward-looking statements strongly indicate this is a presentation prepared for investors or analysts, likely following an earnings announcement or as part of an annual review cycle. This aligns perfectly with the definition of an Investor Presentation (IP). It is not a full 10-K, a short ER, or a simple announcement (RPA/RNS) as it contains substantial, detailed content.
2022-03-22 Spanish
Motivo de la notificación: Persona Estrechamente Vinculada
Director's Dealing Classification · 100% confidence The document is titled "MODELO DE NOTIFICACIÓN DE LAS OPERACIONES DE LAS PERSONAS CON RESPONSABILIDADES DE DIRECCIÓN Y DE LAS PERSONAS ESTRECHAMENTE VINCULADAS CON ELLAS" (Standard Form for Notification and Public Disclosure of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with Them). This form explicitly details transactions (buying/selling shares, indicated by 'Naturaleza de la operación' and volume/price data) conducted by insiders or related parties of the issuer (FAES FARMA, S.A.). This directly corresponds to the definition of Director's Dealing (insider trades). The filing type code for Director's Dealing is DIRS.
2022-03-07 Spanish

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.